标题
The Importance of microRNAs in RAS Oncogenic Activation in Human Cancer
作者
关键词
-
出版物
Frontiers in Oncology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-09-27
DOI
10.3389/fonc.2019.00988
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- miR-100-5p confers resistance to ALK tyrosine kinase inhibitors Crizotinib and Lorlatinib in EML4-ALK positive NSCLC
- (2019) Yi Lai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer
- (2019) Xin-Ge Zhao et al. Cell Death & Disease
- MicroRNA-7 Exerts Antiangiogenic Effect on Colorectal Cancer via ERK Signaling
- (2019) Xuepeng Fan et al. JOURNAL OF SURGICAL RESEARCH
- MiR-181a contributes gefitinib resistance in non-small cell lung cancer cells by targeting GAS7
- (2018) Wei Ping et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR‐205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling
- (2018) Cristina Migliore et al. EMBO Molecular Medicine
- MicroRNA degradation by a conserved target RNA regulates animal behavior
- (2018) Angelo Bitetti et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3
- (2018) Jinnan Yue et al. ONCOGENE
- MicroRNA degradation by a conserved target RNA regulates animal behavior
- (2018) Angelo Bitetti et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- miR-539 acts as a tumor suppressor by targeting epidermal growth factor receptor in breast cancer
- (2018) Jilong Guo et al. Scientific Reports
- A low microRNA-630 expression confers resistance to tyrosine kinase inhibitors in EGFR-mutated lung adenocarcinomas via miR-630/YAP1/ERK feedback loop
- (2018) De-Wei Wu et al. Theranostics
- miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model
- (2018) Elisa Callegari et al. Molecular Therapy-Nucleic Acids
- MicroRNAs as a drug resistance mechanism to targeted therapies in EGFR-mutated NSCLC: Current implications and future directions
- (2018) Alessandro Leonetti et al. DRUG RESISTANCE UPDATES
- miRBase: from microRNA sequences to function
- (2018) Ana Kozomara et al. NUCLEIC ACIDS RESEARCH
- miR‑101 regulates the cell proliferation and apoptosis in diffuse large B‑cell lymphoma by targeting MEK1 via regulation of the ERK/MAPK signaling pathway
- (2018) Yiqun Huang et al. ONCOLOGY REPORTS
- New insights in melanoma resistance to BRAF inhibitors: a role for microRNAs
- (2018) Marta Díaz-Martínez et al. Oncotarget
- Wild type Kirsten rat sarcoma is a novel microRNA-622-regulated therapeutic target for hepatocellular carcinoma and contributes to sorafenib resistance
- (2017) Peter Dietrich et al. GUT
- Inhibition of miR-23a increases the sensitivity of lung cancer stem cells to erlotinib through PTEN/PI3K/Akt pathway
- (2017) Zhijun Han et al. ONCOLOGY REPORTS
- MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2
- (2017) Alip Ghosh et al. Cell Death & Disease
- LncRNA SNHG12 contributes to multidrug resistance through activating the MAPK/Slug pathway by sponging miR-181a in non-small cell lung cancer
- (2017) Pei Wang et al. Oncotarget
- Down-regulation of miR-214 reverses erlotinib resistance in non-small-cell lung cancer through up-regulating LHX6 expression
- (2017) Jinrong Liao et al. Scientific Reports
- miR-134: A Human Cancer Suppressor?
- (2017) Jing-Yu Pan et al. Molecular Therapy-Nucleic Acids
- MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways
- (2016) Yanmin Xu et al. CANCER LETTERS
- miR-223 enhances the sensitivity of non-small cell lung cancer cells to erlotinib by targeting the insulin-like growth factor-1 receptor
- (2016) FENG-YI ZHAO et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- miR-223 reverses the resistance of EGFR-TKIs through IGF1R/PI3K/Akt signaling pathway
- (2016) JING HAN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- miR-134 inhibits non-small cell lung cancer growth by targeting the epidermal growth factor receptor
- (2016) Qin Qin et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Endogenous microRNA sponges: evidence and controversy
- (2016) Daniel W. Thomson et al. NATURE REVIEWS GENETICS
- miR-579-3p controls melanoma progression and resistance to target therapy
- (2016) Luigi Fattore et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-134 modulates glioma cell U251 proliferation and invasion by targeting KRAS and suppressing the ERK pathway
- (2016) Yuguang Zhao et al. TUMOR BIOLOGY
- miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways
- (2016) Xiaoyan Sun et al. Oncotarget
- MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patients
- (2016) Magdalena Lukamowicz-Rajska et al. Oncotarget
- miR-26a desensitizes non-small cell lung cancer cells to tyrosine kinase inhibitors by targeting PTPN13
- (2016) Shudi Xu et al. Oncotarget
- miR-143 or miR-145 overexpression increases cetuximab-mediated antibody-dependent cellular cytotoxicity in human colon cancer cells
- (2016) Sofia E. Gomes et al. Oncotarget
- miRs-134 and -370 function as tumor suppressors in colorectal cancer by independently suppressing EGFR and PI3K signalling
- (2016) Sherien M. El-Daly et al. Scientific Reports
- miR-134 Functions as a Tumor Suppressor in Cell Proliferation and Epithelial-to-Mesenchymal Transition by Targeting KRAS in Renal Cell Carcinoma Cells
- (2015) Yiyang Liu et al. DNA AND CELL BIOLOGY
- The Role of miR-21 in Cancer
- (2015) Susan R. Pfeffer et al. DRUG DEVELOPMENT RESEARCH
- Potent degradation of neuronal miRNAs induced by highly complementary targets
- (2015) M. de la Mata et al. EMBO REPORTS
- The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications
- (2015) Bénédicte Delire et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action
- (2015) Julien Masliah-Planchon et al. Oncotarget
- MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma
- (2015) Lin Wang et al. Oncotarget
- miR-524-5p suppresses the growth of oncogenic BRAF melanoma by targeting BRAF and ERK2
- (2015) Szu-Mam Liu et al. Oncotarget
- miR-138-5p reverses gefitinib resistance in non-small cell lung cancer cells via negatively regulating G protein-coupled receptor 124
- (2014) Yi Gao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A let-7 microRNA polymorphism in the KRAS 3′-UTR is prognostic in oropharyngeal cancer
- (2014) Kim De Ruyck et al. Cancer Epidemiology
- Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B and glioblastoma
- (2014) Y Zhang et al. CELL DEATH AND DIFFERENTIATION
- Alteration in Mir-21/PTEN Expression Modulates Gefitinib Resistance in Non-Small Cell Lung Cancer
- (2014) Hua Shen et al. PLoS One
- Axl-altered microRNAs regulate tumorigenicity and gefitinib resistance in lung cancer
- (2014) Y Wang et al. Cell Death & Disease
- MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway
- (2013) Xin Yang et al. HEPATOLOGY
- miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor
- (2013) Martin Pichler et al. JOURNAL OF CLINICAL PATHOLOGY
- MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer
- (2013) Bing Li et al. LUNG CANCER
- High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth
- (2013) Suvi-Katri Leivonen et al. Molecular Oncology
- Overexpression of miR-145 increases the sensitivity of vemurafenib in drug-resistant colo205 cell line
- (2013) Wei Peng et al. TUMOR BIOLOGY
- Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups
- (2013) Nature Communications
- MicroRNA-214 Regulates the Acquired Resistance to Gefitinib via the PTEN/AKT Pathway in EGFR-mutant Cell Lines
- (2012) Yong-Sheng Wang et al. Asian Pacific Journal of Cancer Prevention
- Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression
- (2012) A Pagliuca et al. ONCOGENE
- High Let-7a MicroRNA Levels in KRAS-Mutated Colorectal Carcinomas May Rescue Anti-EGFR Therapy Effects in Patients with Chemotherapy-Refractory Metastatic Disease
- (2012) A. Ruzzo et al. ONCOLOGIST
- MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors
- (2012) Long R. Jiao et al. PLoS One
- Regulation of let-7 and its target oncogenes (Review)
- (2012) XIRUI WANG et al. Oncology Letters
- MicroRNA-21: A novel therapeutic target in human cancer
- (2011) Xuan Pan et al. CANCER BIOLOGY & THERAPY
- MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer
- (2011) Hiroshi Hirata et al. CARCINOGENESIS
- A Let-7 MicroRNA SNP in the KRAS 3'UTR Is Prognostic in Early-Stage Colorectal Cancer
- (2011) K. M. Smits et al. CLINICAL CANCER RESEARCH
- miR221/222 in Cancer: Their Role in Tumor Progression and Response to Therapy
- (2011) M. Garofalo et al. CURRENT MOLECULAR MEDICINE
- MicroRNAs and developmental timing
- (2011) Victor Ambros CURRENT OPINION IN GENETICS & DEVELOPMENT
- The Evi1, microRNA-143, K-Ras axis in colon cancer
- (2011) Jin-Song Gao et al. FEBS LETTERS
- MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2
- (2011) Xie-Feng Wang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Liposomal Delivery of MicroRNA-7-Expressing Plasmid Overcomes Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Resistance in Lung Cancer Cells
- (2011) K. Rai et al. MOLECULAR CANCER THERAPEUTICS
- EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers
- (2011) Michela Garofalo et al. NATURE MEDICINE
- miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras
- (2010) Ki-Hyuk Shin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
- (2010) Mark E. Hatley et al. CANCER CELL
- miRNA-96 Suppresses KRAS and Functions as a Tumor Suppressor Gene in Pancreatic Cancer
- (2010) S. Yu et al. CANCER RESEARCH
- The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS
- (2010) Wu-Gan Zhao et al. CARCINOGENESIS
- Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis
- (2010) Yutaka Hashimoto et al. CARCINOGENESIS
- Thelet-7microRNA reduces tumor growth in mouse models of lung cancer
- (2010) Aurora Esquela-Kerscher et al. CELL CYCLE
- MicroRNA-21 Is Induced Early in Pancreatic Ductal Adenocarcinoma Precursor Lesions
- (2010) M. C. du Rieu et al. CLINICAL CHEMISTRY
- Downregulation of miR-21 modulates Ras expression to promote apoptosis and suppress invasion of Laryngeal squamous cell carcinoma
- (2010) Jingyuan Ren et al. EUROPEAN JOURNAL OF CANCER
- KRAS and BRAF: drug targets and predictive biomarkers
- (2010) Efsevia Vakiani et al. JOURNAL OF PATHOLOGY
- Upregulation of miR-21 by Ras in vivo and its role in tumor growth
- (2010) D Frezzetti et al. ONCOGENE
- The role of let-7 in cell differentiation and cancer
- (2009) Benjamin Boyerinas et al. ENDOCRINE-RELATED CANCER
- Modulation of microRNA processing by p53
- (2009) Hiroshi I. Suzuki et al. NATURE
- Role of miR-143 targeting KRAS in colorectal tumorigenesis
- (2009) X Chen et al. ONCOGENE
- Regression of murine lung tumors by the let-7 microRNA
- (2009) P Trang et al. ONCOGENE
- MicroRNAs in Cancer
- (2008) Yong Sun Lee et al. Annual Review of Pathology-Mechanisms of Disease
- A SNP in a let-7 microRNA Complementary Site in the KRAS 3' Untranslated Region Increases Non-Small Cell Lung Cancer Risk
- (2008) L. J. Chin et al. CANCER RESEARCH
- Most mammalian mRNAs are conserved targets of microRNAs
- (2008) R. C. Friedman et al. GENOME RESEARCH
- Lin28 Mediates the Terminal Uridylation of let-7 Precursor MicroRNA
- (2008) Inha Heo et al. MOLECULAR CELL
- A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment
- (2008) Agnieszka Rybak et al. NATURE CELL BIOLOGY
- Suppression of non-small cell lung tumor development by the let-7 microRNA family
- (2008) M. S. Kumar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing
- (2008) M. A. Newman et al. RNA
- Selective Blockade of MicroRNA Processing by Lin28
- (2008) S. R. Viswanathan et al. SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started